Strong Industry Presence Angelini Pharma operates within the pharmaceutical manufacturing sector with a robust team of up to 10,000 employees and annual revenues ranging from one to ten billion dollars, positioning it as a significant player in the European pharmaceutical market and offering substantial opportunities for strategic partnerships and product distribution.

Innovative CNS Focus The company's dedicated pipeline growth and recent development of SVG105 for brain health disorders, along with collaborations in epilepsy treatment, highlight a clear focus on CNS and mental health therapies, creating opportunities for sales of specialized medical supplies, diagnostic tools, and complementary therapies.

Research & Collaborations Angelini Pharma's active partnerships with research institutes and biotech firms like GRIN Therapeutics suggest a continued emphasis on innovative treatments, presenting prospects for advanced research equipment, licensing opportunities, and collaborative development of new products.

Digital & Data Engagement Utilizing modern technology including Google Analytics and Salesforce Marketing Cloud, the company demonstrates engagement with digital marketing and data-driven insights, opening doors for sales of marketing automation software, analytics tools, and digital health solutions.

Recognition & Market Position Awarded Top Employer for six consecutive years, Angelini Pharma’s strong employer brand and market presence offer sales potential in corporate wellness, HR solutions, and employee engagement tools, alongside its core pharmaceutical products.